139 related articles for article (PubMed ID: 24798933)
1. Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Ding XP; Feng L; Ma L
Arch Gynecol Obstet; 2014 Oct; 290(4):741-7. PubMed ID: 24798933
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Chu Y; Zheng A; Wang F; Lin W; Yang X; Han L; Chen Y; Bai L
Nucl Med Commun; 2014 Feb; 35(2):144-50. PubMed ID: 24177043
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET for management of cervical and ovarian cancer.
Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
[TBL] [Abstract][Full Text] [Related]
6. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR
J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Lin CY; Chen JH; Liang JA; Lin CC; Jeng LB; Kao CH
Eur J Radiol; 2012 Sep; 81(9):2417-22. PubMed ID: 21899970
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography.
Park DH; Kim KH; Park SY; Lee BH; Choi CW; Chin SY
Korean J Radiol; 2000; 1(1):51-5. PubMed ID: 11752929
[TBL] [Abstract][Full Text] [Related]
10. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
[TBL] [Abstract][Full Text] [Related]
11. Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation.
Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Auguste P; Barton P; Roberts T; Khan K; Sundar S
BJOG; 2014 Mar; 121(4):398-407. PubMed ID: 24299154
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Xiao Y; Wang L; Jiang X; She W; He L; Hu G
Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
14. Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.
Chatziioannou SN; Georgakopoulos AT; Pianou NK; Kafiri GT; Pavlou SN; Kallergi M
Acad Radiol; 2014 Jan; 21(1):58-63. PubMed ID: 24331265
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Cheng X; Bao L; Xu Z; Li D; Wang J; Li Y
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):136-42. PubMed ID: 22498184
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R
J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficacy of PET and PET/CT for recurrent lung cancer: a meta-analysis.
He YQ; Gong HL; Deng YF; Li WM
Acta Radiol; 2014 Apr; 55(3):309-17. PubMed ID: 24081215
[TBL] [Abstract][Full Text] [Related]
18. The role of PET/CT in the management of cervical cancer.
Mirpour S; Mhlanga JC; Logeswaran P; Russo G; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2013 Aug; 201(2):W192-205. PubMed ID: 23883234
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Chung HH; Jo H; Kang WJ; Kim JW; Park NH; Song YS; Chung JK; Kang SB; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):529-34. PubMed ID: 17049971
[TBL] [Abstract][Full Text] [Related]
20. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.
Lu YY; Chen JH; Chien CR; Chen WT; Tsai SC; Lin WY; Kao CH
Int J Colorectal Dis; 2013 Aug; 28(8):1039-47. PubMed ID: 23407908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
